CG Oncology, Inc. (CGON) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

CG Oncology, Inc. (CGON) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

CG Oncology, Inc.

· CGON

Dashboard

Financials

Ratios

Valuation

Statistics

6.251 B

+0.52%

General

Market Cap: $6.25B
Enterprise Value: $6.24B
Shares Outstanding: 88,200,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: -82.69%
Operating Margin: -4056.18%
Net Profit Margin: -3602.68%
FCF Margin: -2879.62%
ROA: -20.67%
ROE: -25.20%
ROIC: -24.30%
Current Ratio: 22.22
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.43
P/S: 1003.96
P/FCF: —
P/B: 6.08
EV/EBITDA: -28.08

Growth

Rev 1Y: 254.70%
Rev 1Y Fwd Est: 6.97%
Rev 3Y (CAGR): 176.56%
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $6.23M
Gross Margin: -82.69%
Operating Expenses: $247.47M
Operating Income: -$252.62M
Net Profit: -$224.38M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $19.64M
Working Capital: $1B
Total Assets: $1.09B
Net Debt: -$10.82M
Total Liabilities: $56.54M
Total Equity: $1.03B

Cash Flow Statement (TTM)

Cash Flow from Operations: -$178.47M
Cash Flow from Investing: -$364.88M
Cash Flow from Financing: $548.36M
Free Cash Flow: -$179.34M
Capital Expenditures: $876K